NNM Securities
ABOUT US
SERVICES
EQUITY
COMMODITY
CURRENCY
DERIVATIVES
MUTUAL FUND
ADVISORY
FINANCING
MARKET INFO
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
RESEARCH
CONTACT US
LOGIN
Gallery
Open Account Meon
Open Account
Partner Us
Downloads
COMPANY
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
more from company profile
General
Smart Quotes
Company Information
Comparison
Company News
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Cash Flow
Holdings
Share Holdings
MF Holdings
Digital Reports
Corp Actions
Board Meeting
Book Closure
Bonus Issues
Dividend Details
Price Info
Share Price
Historical Volume
Deliverable Volume
Bulk Deals
Block Deals
Price Charts
Home
Market Info
Company Profile
Quarterly Results
Quarterly Results
GLAXOSMITHKLINE PHARMACEUTICALS LTD.
NSE :
GLAXO
BSE :
500660
ISIN CODE :
INE159A01016
Industry :
Pharmaceuticals & Drugs
House :
Glaxosmithkline - MNC
BSE
2070.90
-8.9 (-0.43 %)
PREV CLOSE (
)
2079.80
OPEN PRICE (
)
2080.40
BID PRICE (QTY)
2070.25 (14)
OFFER PRICE (QTY)
2075.30 (6)
VOLUME
9964
TODAY'S LOW / HIGH (
)
2039.75
2118.00
52 WK LOW / HIGH (
)
1228
2649.95
NSE
2065.05
-12.2 (-0.59 %)
PREV CLOSE(
)
2077.25
OPEN PRICE (
)
2078.00
BID PRICE (QTY)
2065.30 (2)
OFFER PRICE (QTY)
2066.75 (7)
VOLUME
90013
TODAY'S LOW / HIGH(
)
2041.00
2118.00
52 WK LOW / HIGH (
)
1227
2524
Consolidated
Standalone
Quarters
3
4
5
6
7
8
Rs.in Crore
Rs. in Million
GO
Dec2023
Sep2023
Jun2023
Mar2023
(
in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
8052.60
9569.90
7616.60
7874.50
Total Expenditure
5872.00
6675.00
6177.80
6177.10
PBIDT (Excl OI)
2180.60
2894.90
1438.80
1697.40
Other Income
281.10
282.10
364.40
276.60
Operating Profit
2461.70
3177.00
1803.20
1974.00
Interest
3.20
4.30
2.80
6.50
Exceptional Items
-1633.10
NA
173.00
104.00
PBDT
825.40
3172.70
1973.40
2071.50
Depreciation
171.10
181.10
163.60
171.80
Profit Before Tax
654.30
2991.60
1809.80
1899.70
Tax
197.10
816.50
487.30
565.40
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
457.20
2175.10
1322.50
1334.30
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
457.20
2175.10
1322.50
1334.30
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
457.20
2175.10
1322.50
1334.30
Equity Capital
1694.10
1694.10
1694.10
1694.10
Face Value (IN RS)
10.00
10.00
10.00
10.00
Reserves
NA
NA
NA
NA
Calculated EPS
2.70
12.84
7.81
7.88
Calculated EPS (Annualised)
10.80
51.36
31.23
31.50
No of Public Share Holdings
42351510.00
42351510.00
42351510.00
42351510.00
% of Public Share Holdings
25.00
25.00
25.00
25.00
NA
NA
NA
NA
PBIDTM% (Excl OI)
27.08
30.25
18.89
21.56
PBIDTM%
30.57
33.20
23.67
25.07
PBDTM%
10.25
33.15
25.91
26.31
PBTM%
8.13
31.26
23.76
24.12
PATM%
5.68
22.73
17.36
16.94
Notes
Notes
Notes
Notes
X